DK3220937T3 - Pneumolysinmutanter og fremgangsmåder til anvendelse deraf - Google Patents

Pneumolysinmutanter og fremgangsmåder til anvendelse deraf Download PDF

Info

Publication number
DK3220937T3
DK3220937T3 DK15861711.8T DK15861711T DK3220937T3 DK 3220937 T3 DK3220937 T3 DK 3220937T3 DK 15861711 T DK15861711 T DK 15861711T DK 3220937 T3 DK3220937 T3 DK 3220937T3
Authority
DK
Denmark
Prior art keywords
methods
pneumolysin mutants
pneumolysin
mutants
Prior art date
Application number
DK15861711.8T
Other languages
Danish (da)
English (en)
Inventor
Rodney K Tweten
Original Assignee
Univ Oklahoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Oklahoma filed Critical Univ Oklahoma
Application granted granted Critical
Publication of DK3220937T3 publication Critical patent/DK3220937T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
DK15861711.8T 2014-11-21 2015-11-20 Pneumolysinmutanter og fremgangsmåder til anvendelse deraf DK3220937T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462082848P 2014-11-21 2014-11-21
PCT/US2015/061859 WO2016081839A1 (en) 2014-11-21 2015-11-20 Pneumolysin mutants and methods of use thereof

Publications (1)

Publication Number Publication Date
DK3220937T3 true DK3220937T3 (da) 2024-12-02

Family

ID=56014598

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15861711.8T DK3220937T3 (da) 2014-11-21 2015-11-20 Pneumolysinmutanter og fremgangsmåder til anvendelse deraf

Country Status (21)

Country Link
US (1) US10562941B2 (enExample)
EP (2) EP4501949A3 (enExample)
JP (1) JP6734274B2 (enExample)
KR (1) KR102304828B1 (enExample)
CN (1) CN107106635B (enExample)
AU (1) AU2015349787B2 (enExample)
CA (1) CA2968398A1 (enExample)
DK (1) DK3220937T3 (enExample)
ES (1) ES2993430T3 (enExample)
FI (1) FI3220937T3 (enExample)
HR (1) HRP20241627T1 (enExample)
HU (1) HUE069200T2 (enExample)
LT (1) LT3220937T (enExample)
MX (1) MX381872B (enExample)
PL (1) PL3220937T3 (enExample)
PT (1) PT3220937T (enExample)
RS (1) RS66221B1 (enExample)
SI (1) SI3220937T1 (enExample)
SM (1) SMT202400482T1 (enExample)
WO (1) WO2016081839A1 (enExample)
ZA (1) ZA201703881B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012134975A1 (en) 2011-03-28 2012-10-04 St. Jude Children's Research Hospital Methods and compositions employing immunogenic fusion proteins
WO2018124959A2 (en) 2016-12-28 2018-07-05 Henriques Normark Birgitta Microparticles from streptococcus pneumoniae as vaccine antigens
CN110967482B (zh) * 2018-09-30 2023-04-07 重庆市畜牧科学院 一种山羊化脓隐秘杆菌感染检测试剂盒及其检测方法
CN113264999B (zh) * 2021-04-29 2023-02-28 星济生物(苏州)有限公司 中和肺炎链球菌溶血素蛋白的抗原结合蛋白及其用途
WO2023039223A1 (en) * 2021-09-09 2023-03-16 Affinivax, Inc. Multivalent pneumococcal vaccines
JP2024541094A (ja) 2021-11-18 2024-11-06 マトリバックス,インコーポレイティド 免疫原性融合タンパク質組成物及びその使用の方法
CN115927420A (zh) * 2022-05-27 2023-04-07 贵州省畜牧兽医研究所 一种溶血素重组表达及间接elisa检测方法及应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4686102A (en) 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
US6716432B1 (en) 1988-12-16 2004-04-06 James Cleland Paton Pneumolysin mutants and pneumococcal vaccines made therefrom
CA2005704C (en) 1988-12-16 2003-02-11 James C. Paton Pneumolysin mutants and pneumococcal vaccines made therefrom
US5854416A (en) 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US5565204A (en) 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
WO1996040930A1 (en) 1995-06-07 1996-12-19 Regents Of The University Of Minnesota Mutants of streptococcal toxin a and methods of use
US6764686B2 (en) 1997-07-21 2004-07-20 Baxter International Inc. Modified immunogenic pneumolysin compositions as vaccines
US6224880B1 (en) 1997-09-24 2001-05-01 Merck & Co., Inc. Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines
US6903184B1 (en) 1998-03-02 2005-06-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Multiple antigenic peptides immunogenic against Streptococcus pneumonia
PL204863B1 (pl) 1998-07-22 2010-02-26 Stichting Dienst Landbouwkundi Zastosowanie mutanta Streptococcus, szczepionka i sposoby kontrolowania lub eliminowania choroby paciorkowcowej w populacji
DK1140157T3 (da) 1998-12-21 2009-06-08 Medimmune Inc Streptococcus pneumoniae-proteiner og immunogene fragmenter til vacciner
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
WO2003054007A2 (en) 2001-12-20 2003-07-03 Shire Biochem Inc. Streptococcus antigens
US7217791B2 (en) 2002-11-07 2007-05-15 Synergy America, Inc. Compositions and methods for treating or preventing pneumococcal infection
US20060257421A1 (en) 2004-02-13 2006-11-16 Martina Ochs Pneumolysin derivatives
WO2005108419A1 (en) 2004-05-07 2005-11-17 Lea-Ann Kirkham Mutant cholesterol-binding cytolysin proteins
GB0410220D0 (en) * 2004-05-07 2004-06-09 Kirkham Lea Ann Mutant pneumolysin proteins
US9370557B2 (en) 2006-06-15 2016-06-21 The University Court Of The University Of Glasgow Adjuvant compounds
BRPI0810211A2 (pt) * 2007-04-13 2014-10-21 Univ Oklahoma Citolisina dependente de colesterol mutante purficada, composição, vacina, método para vacinar um paciente, anticorpo monoclonal, ácido nucléico, e, célula hospedeira.
CN106008679A (zh) 2008-12-24 2016-10-12 荷兰王国卫生福利和运动部国家公共卫生和环境研究所 修饰的肺炎链球菌溶血素(ply)多肽
CN102939105B (zh) * 2009-12-22 2016-11-16 赛诺菲巴斯德有限公司 免疫原性组合物和相关的方法
CL2010001216A1 (es) * 2010-11-08 2011-01-28 New Tech Copper S P A Sistema para confinar el espacio sobre el electrolito en una celda de electro obtencion y evacuar los aerosoles generados, que comprende un confinador insertado en cada anodo, con un par de proyecciones flexibles y un par de perfiles en angulo, y ductos longitudinales con perforaciones sobre el nivel del electrolito.
WO2012134975A1 (en) 2011-03-28 2012-10-04 St. Jude Children's Research Hospital Methods and compositions employing immunogenic fusion proteins
JP6397805B2 (ja) 2015-08-28 2018-09-26 東芝メモリ株式会社 半導体製造装置およびその運転方法

Also Published As

Publication number Publication date
KR20170083635A (ko) 2017-07-18
AU2015349787B2 (en) 2021-07-29
MX381872B (es) 2025-03-13
AU2015349787A1 (en) 2017-06-22
JP6734274B2 (ja) 2020-08-05
EP3220937B1 (en) 2024-09-04
ES2993430T3 (en) 2024-12-30
EP3220937A1 (en) 2017-09-27
LT3220937T (lt) 2024-12-27
PL3220937T3 (pl) 2025-01-27
US20180312552A1 (en) 2018-11-01
HUE069200T2 (hu) 2025-02-28
JP2017536124A (ja) 2017-12-07
EP4501949A3 (en) 2025-04-30
EP3220937A4 (en) 2018-05-30
WO2016081839A1 (en) 2016-05-26
MX2017006625A (es) 2018-01-15
ZA201703881B (en) 2021-10-27
RS66221B1 (sr) 2024-12-31
KR102304828B1 (ko) 2021-09-27
HRP20241627T1 (hr) 2025-02-14
EP4501949A2 (en) 2025-02-05
SMT202400482T1 (it) 2025-01-14
CN107106635B (zh) 2021-10-08
US10562941B2 (en) 2020-02-18
CN107106635A (zh) 2017-08-29
SI3220937T1 (sl) 2025-03-31
BR112017010696A2 (pt) 2017-12-26
PT3220937T (pt) 2024-11-18
FI3220937T3 (fi) 2024-11-29
CA2968398A1 (en) 2016-05-26

Similar Documents

Publication Publication Date Title
IL286316A (en) New micro-dystrophins and related method of use
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3215532T3 (da) Anti-TIM3-antistoffer og fremgangsmåder til anvendelse
DK3234133T3 (da) Crispr-baserede sammensætninger og fremgangsmåder til anvendelse
IL250415B (en) Antibodies against pd-l and methods of using them
DK3353210T3 (da) Anti-TIGIT-antistoffer og fremgangsmåder til anvendelse
DK3209308T3 (da) Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf
DK3436048T3 (da) Neoantigener og fremgangsmåder til anvendelse deraf
DK3394065T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf
DK3230319T3 (da) Anti-PD-1-antistoffer og fremgangsmåder til anvendelse deraf
DK3201351T3 (da) Kaloriefrie sødestoffer og fremgangsmåder til syntetisering
DK3126394T3 (da) Anti-OX40-antistoffer og fremgangsmåder til anvendelse
DK3089971T3 (da) Forbindelser og fremgangsmåder til anvendelse
DK3215147T3 (da) Neurodæmpende norketamin-forbindelser og fremgangsmåder
DK3653221T3 (da) Anti-pvrig-antistoffer og anvendelsesfremgangsmåder
DK3227336T3 (da) Anti-CD79b-antistoffer og fremgangsmåder til anvendelse
DK3828194T3 (da) Oxysteroler og fremgangsmåder til anvendelse deraf
ZA201608116B (en) Wireline system and methods of using same
SI3218005T1 (sl) Z glikanom delujoče spojine, in postopki uporabe
DK3812392T3 (da) Oxysteroler og fremgangsmåder til anvendelse deraf
DK3514151T3 (da) Proteinkinase-C-hæmmere og fremgangsmåder til anvendelse deraf
GB2546006B (en) Downhole apparatus and methods of use
DK3220937T3 (da) Pneumolysinmutanter og fremgangsmåder til anvendelse deraf
DK3183201T3 (da) Spilsamling og fremgangsmåde til anvendelse
DK3177642T3 (da) Angiopoietin-lignende 4-antistoffer og fremgangsmåder til anvendelse deraf